PASCAL versus MitraClip-XTR edge-to-edge device for the treatment of tricuspid regurgitation: a propensity-matched analysis.

Atsushi SugiuraJohanna VogelhuberCan ÖztürkZita SchwaiboldDavid ReckersTadahiro GotoRefik KavsurMarc Ulrich BecherSebastian ZimmerGeorg NickenigMarcel Weber

Published in: Clinical research in cardiology : official journal of the German Cardiac Society (2020)

Both TTVR devices, PASCAL and MitraClip-XTR, appeared feasible and comparable for an effective TR reduction. Randomized head-to-head comparisons will help to further define the appropriate scope of application of each system.

Keyphrases

mitral valve
aortic valve
optic nerve
open label
double blind
aortic stenosis
left ventricular
phase iii
clinical trial
randomized controlled trial
atrial fibrillation
replacement therapy